Nutrien Tidigare resultatutveckling
Tidigare kriterier kontrolleras 4/6
Nutrien s intäkter har minskat med en genomsnittlig årlig takt på -19.2%, medan Chemicals -branschen såg intäkter på växande på 12.4% årligen. Intäkterna har varit fallande med en genomsnittlig takt på 1.4% per år. Nutrien s avkastning på eget kapital är 9.6% och den har en nettomarginal på 8.9%.
Viktig information
-19.25%
Tillväxttakt i vinsten
-16.39%
Tillväxttakt för EPS
| Chemicals Tillväxt i branschen | 4.55% |
| Intäkternas tillväxttakt | -1.38% |
| Avkastning på eget kapital | 9.59% |
| Nettomarginal | 8.88% |
| Nästa resultatuppdatering | 06 Aug 2026 |
Senaste uppdateringar av tidigare prestationer
Recent updates
Analysuppdatering • May 03
NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Future Returns
The updated analyst price target for Nutrien reflects a small decrease of about CA$0.26. Analysts are balancing slightly softer implied revenue growth and a marginally higher discount rate against firmer profit margin assumptions and a modestly lower future P/E multiple.
Analysuppdatering • Apr 19
NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Balanced Outlook
The analyst price target for Nutrien has risen by CA$4.18. Analysts attribute this change to updated assumptions for slightly stronger revenue growth, higher profit margins, and a lower future P/E multiple, reflecting the recent wave of higher sector targets and tighter global fertilizer markets.Analysuppdatering • Apr 04
NTR: Tighter Fertilizer Markets And DOJ Probe Will Pressure Future Returns
Analysts have nudged the fair value estimate for Nutrien higher to CA$95.41. This reflects a modestly lower discount rate, slightly firmer long term margin assumptions, and updated sector P/E comparisons that incorporate a wave of recent price target increases tied to tighter fertilizer markets and higher commodity pricing expectations.Analysuppdatering • Mar 21
NTR: Higher Fertilizer Pricing And DOJ Probe Will Shape Share Performance
Analysts have lifted the average Nutrien price target by roughly CA$31 to around CA$95, citing stronger fertilizer pricing, higher expected profit margins and support for elevated sector valuation multiples, despite more cautious views on volume growth. Analyst Commentary Recent research on Nutrien largely centers on fertilizer pricing, geopolitical risks and the earnings impact of tighter nitrogen and potash markets.Analysuppdatering • Mar 07
NTR: Nutrient Pricing, Portfolio Actions And DOJ Probe Will Shape Balanced Outlook
The analyst price target for Nutrien has increased to CA$101.07 from CA$96.56, as analysts factor in firmer nutrient pricing expectations, potential nitrogen upside tied to recent geopolitical events, and company-specific portfolio actions that they view as supportive of earnings stability and cash generation. Analyst Commentary Recent research points to a broadly constructive tone around Nutrien, with multiple firms updating models after the Q4 report and adjusting price targets on the back of nutrient pricing assumptions, portfolio moves, and expected cash generation.Analysuppdatering • Feb 21
NTR: Firmer Nutrient Pricing And Potash Supply Risks Will Shape Balanced Returns
Our updated fair value estimate for Nutrien edges higher to CA$96.56 from CA$91.99, reflecting a series of analyst price target increases tied to refreshed models after recent results, stronger assumed profit margins, and expectations that nutrient pricing holds firmer for longer, even as some remain cautious about future potash supply. Analyst Commentary Street research on Nutrien has been active, with several firms revisiting their models and adjusting price targets around recent and upcoming quarterly results.Analysuppdatering • Feb 07
NTR: Reassessed P/E And Farm Headwinds Will Shape Balanced Returns Ahead
Analysts have raised our Nutrien fair value estimate to $91.99 from $88.43, as recent price target increases and rating changes suggest a reassessment of the stock's risk profile, growth outlook, and appropriate future P/E multiple. Analyst Commentary Recent Street research on Nutrien has become more constructive, with several firms increasing price targets or improving ratings while others remain cautious on end market conditions and sector headwinds.
Analysuppdatering • Jan 23
NTR: Higher Fertilizer Pricing And Buybacks Will Support Future Upside
Our analyst price target for Nutrien edges slightly lower to about $112.49 from $113.03, as analysts weigh mixed sector commentary on fertilizer and agriculture markets against recent target adjustments and an updated future P/E assumption of roughly 20.2x. Analyst Commentary Recent Street research on Nutrien reflects mixed sector views but a generally supportive tone on the company, with several bullish analysts adjusting targets and ratings while acknowledging a more cautious backdrop for fertilizers and agriculture.Analysuppdatering • Jan 09
NTR: Fertilizer Cycle Concerns Will Pressure Shares Despite Recent Buybacks
Narrative Update Analysts have nudged their consolidated price target for Nutrien down by about $2 to $64. This reflects updated views that factor in more cautious fertilizer and agriculture setups, modestly lower assumed revenue growth, a slightly higher profit margin profile, and a reduced future P/E multiple in their models.Analysuppdatering • Dec 21
NTR Is Expected To Benefit From Potential Upside In Fertilizer Pricing
Analysts have modestly reduced their price target on Nutrien to approximately $113 from about $97, citing a tougher near term backdrop for farmers, slightly lower growth and margin expectations, and a more balanced risk reward profile after the stock's strong run. Analyst Commentary Recent Street research reflects a mixed but generally constructive stance on Nutrien, with several firms trimming price targets modestly while maintaining positive ratings.Analysuppdatering • Dec 07
NTR: Portfolio Streamlining And Farm Headwinds Will Shape Balanced Returns Ahead
Analysts have modestly reduced their price expectations for Nutrien, trimming the target by a low single digit dollar amount to reflect a tougher near term farm income backdrop, portfolio streamlining impacts, and a more balanced risk reward view despite solid recent execution. Analyst Commentary Street research on Nutrien reflects a constructive long term view, tempered by nearer term caution around farm fundamentals, commodity pricing and the impact of recent portfolio moves.Analysuppdatering • Nov 23
NTR: Portfolio Streamlining And Asset Sales Will Drive Sector Outperformance Ahead
Nutrien's analyst price target has been modestly reduced by $0.21 to $88.43. Analysts cite ongoing sector headwinds, including weaker crop prices, portfolio adjustments, and a more balanced risk-reward outlook, despite solid recent performance.Analysuppdatering • Nov 07
NTR: Portfolio Streamlining and Supply Tightness Will Shape Upside Amid Sector Scrutiny
Nutrien’s average analyst price target has edged slightly lower in recent weeks, as analysts weigh a modestly improving profit margin and fair value estimate against easing revenue growth and persistent caution over the agricultural cycle. Analyst Commentary Recent analyst activity around Nutrien highlights both opportunities and challenges for the company as it navigates ongoing market volatility and shifting sector dynamics.Analysuppdatering • Oct 24
Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty
Nutrien's analyst price targets have recently edged lower by $1 to $2 per share, as analysts cite cautious earnings expectations, a more balanced risk-reward profile, and the impact of portfolio adjustments on future performance. Analyst Commentary Recent Street research highlights a divided outlook among analysts covering Nutrien, reflecting both positive and cautionary perspectives as the company navigates its next phase of growth and portfolio transformation.Analysuppdatering • Oct 09
Global Food Demand And Precision Ag Will Secure Fertilizer Success
Analysts have modestly raised their price target for Nutrien, increasing it by approximately $1.38 to reflect updated earnings projections and evolving outlooks for fertilizer market conditions. Analyst Commentary Recent street research reflects a mixed outlook on Nutrien's growth trajectory, valuation, and near-term execution capacity.Analysartikel • Sep 08
With Nutrien Ltd. (TSE:NTR) It Looks Like You'll Get What You Pay For
Nutrien Ltd.'s ( TSE:NTR ) price-to-earnings (or "P/E") ratio of 20.1x might make it look like a sell right now...Analysartikel • Aug 08
Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Shareholders might have noticed that Nutrien Ltd. ( TSE:NTR ) filed its second-quarter result this time last week. The...Analysartikel • Jul 16
Nutrien (TSE:NTR) Has Some Way To Go To Become A Multi-Bagger
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...Analysartikel • Jul 03
A Look At The Fair Value Of Nutrien Ltd. (TSE:NTR)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Nutrien fair value estimate is CA$98.09 Current share price of...
Ny analys • Feb 09
Accelerated Efficiency And Expanded Potash And Nitrogen Output Will Strengthen Future Operations
Accelerated operational efficiency and strategic sales expansion may enhance margins and boost revenue without significant new capital expenditure.Fördelning av intäkter och kostnader
Fördelning av intäkter och kostnader
Hur Nutrien tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.
Resultat- och intäktshistorik
| Datum | Intäkter | Intäkter | G+A Kostnader | FoU-kostnader |
|---|---|---|---|---|
| 31 Mar 26 | 26,877 | 2,387 | 4,215 | 0 |
| 31 Dec 25 | 25,949 | 2,267 | 4,087 | 0 |
| 30 Sep 25 | 25,671 | 1,809 | 4,080 | 0 |
| 30 Jun 25 | 25,021 | 1,363 | 4,090 | 0 |
| 31 Mar 25 | 24,739 | 527 | 4,118 | 0 |
| 31 Dec 24 | 25,016 | 674 | 4,121 | 0 |
| 30 Sep 24 | 25,556 | 733 | 4,207 | 0 |
| 30 Jun 24 | 25,839 | 790 | 4,222 | 0 |
| 31 Mar 24 | 27,325 | 845 | 4,118 | 0 |
| 31 Dec 23 | 28,082 | 1,258 | 4,094 | 0 |
| 30 Sep 23 | 29,967 | 2,198 | 3,949 | 0 |
| 30 Jun 23 | 32,583 | 3,700 | 3,959 | 0 |
| 31 Mar 23 | 35,466 | 6,853 | 3,992 | 0 |
| 31 Dec 22 | 37,012 | 7,660 | 4,050 | 0 |
| 30 Sep 22 | 36,792 | 7,749 | 4,180 | 0 |
| 30 Jun 22 | 34,612 | 6,889 | 4,101 | 0 |
| 31 Mar 22 | 29,868 | 4,404 | 4,015 | 0 |
| 31 Dec 21 | 26,861 | 3,153 | 3,826 | 0 |
| 30 Sep 21 | 23,642 | 2,268 | 3,663 | 0 |
| 30 Jun 21 | 21,861 | 964 | 3,552 | 0 |
| 31 Mar 21 | 20,514 | 621 | 3,409 | 0 |
| 31 Dec 20 | 20,053 | 459 | 3,324 | 0 |
| 30 Sep 20 | 19,534 | 95 | 3,213 | 0 |
| 30 Jun 20 | 19,470 | 823 | 3,084 | 0 |
| 31 Mar 20 | 19,754 | 916 | 3,052 | 0 |
| 31 Dec 19 | 19,316 | 992 | 3,028 | 0 |
| 30 Sep 19 | 19,671 | 1,336 | 2,889 | 0 |
| 30 Jun 19 | 19,449 | 128 | 2,929 | 0 |
| 31 Mar 19 | 18,862 | 11 | 2,930 | 0 |
| 31 Dec 18 | 18,772 | -31 | 2,891 | 0 |
| 30 Sep 18 | 16,051 | -447 | 2,298 | 0 |
| 30 Jun 18 | 13,376 | 636 | 1,631 | 0 |
| 31 Mar 18 | 6,489 | 47 | 829 | 0 |
| 31 Dec 17 | 4,010 | 154 | 233 | 0 |
| 30 Sep 17 | 3,973 | 196 | 218 | 0 |
| 30 Jun 17 | 3,893 | 261 | 221 | 0 |
| 31 Mar 17 | 3,824 | 230 | 233 | 0 |
| 31 Dec 16 | 3,921 | 199 | 231 | 0 |
| 30 Sep 16 | 4,239 | 478 | 253 | 0 |
| 30 Jun 16 | 4,658 | 679 | 246 | 0 |
| 31 Mar 16 | 5,330 | 975 | 251 | 0 |
| 31 Dec 15 | 5,791 | 1,115 | 258 | 0 |
| 30 Sep 15 | 6,303 | 1,476 | 258 | 0 |
| 30 Jun 15 | 6,402 | 1,511 | 255 | 0 |
Kvalitetsintäkter: NTR har inkomster av hög kvalitet.
Växande vinstmarginal: NTR s nuvarande netto vinstmarginaler (8.9%) är högre än förra året (2.1%).
Fritt kassaflöde vs resultatanalys
Analys av tidigare vinsttillväxt
Resultatutveckling: NTR s intäkter har minskat med 19.2% per år under de senaste 5 åren.
Accelererande tillväxt: NTR s intäktstillväxt under det senaste året ( 352.9% ) överstiger sitt 5-åriga genomsnitt ( -19.2% per år).
Resultat vs industri: NTR vinsttillväxt under det senaste året ( 352.9% ) översteg Chemicals branschen 5.3%.
Avkastning på eget kapital
Hög ROE: NTR s avkastning på eget kapital ( 9.6% ) anses vara låg.
Avkastning på tillgångar
Avkastning på sysselsatt kapital
Upptäck starka bolag som tidigare presterat bra
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/07 08:53 |
| Aktiekurs vid dagens slut | 2026/05/07 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Nutrien Ltd. bevakas av 52 analytiker. 14 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Harriet Li | Accountability Research Corporation |
| Keith Carpenter | ATB Cormark |
| Benjamin Theurer | Barclays |